In vitro anti-neoplastic activity of the ethno-pharmaceutical plant Hypericum adenotrichum Spach endemic to Western Turkey

Oncology Reports

Volumn 22, Issue 4, 2009, Pages 845-852

  Özmen, Ali ^a,b   Bauer, Sabine ^b   Gridling, Manuela ^b   Singhuber, Judith ^c   Krasteva, Stanimira ^c   Madlener, Sibylle ^b   Vo, Than Phuong Nha ^b,c   Stark, Nicole ^b   Saiko, Philipp ^b   Fritzer Szekeres, Monika ^b   Szekeres, Thomas ^b   Askin Celik, Tülay ^a   Krenn, Liselotte ^c   Krupitza, Georg ^b  

^a ADNAN MENDERES UNIVERSITY   (Turkey)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF VIENNA   (Austria)

Author keywords

Apoptosis; Cell cycle inhibition; Cyclin D1; Hypericum adenotrichum; Leukaemia

Indexed keywords

ACETIC ACID ETHYL ESTER; ALPHA TUBULIN; CASPASE 3; CYCLIN D1; DICHLOROMETHANE; HISTONE H2AX; HYPERICUM ADENOTRICHUM EXTRACT; METHANOL; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PETROLEUM ETHER; PLANT EXTRACT; PROTEIN P21; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; DRUG ISOLATION; ENZYME ACTIVATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HYPERICUM; HYPERICUM ADENOTRICHUM; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SOLVENT EXTRACTION; UPREGULATION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; HYPERICUM; LEUKEMIA; PHYTOTHERAPY; PLANT EXTRACTS; TURKEY;

EID: 70350359440     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000508     Document Type: Article

References (33)

1. Cragg GM, Newman DJ and Yang SS: Natural product extracts of plant and marine origin having antileukemia potential. The NCI experience. J Nat Prod 69: 488-498, 2006.
2. Baytop T: 'Türkiyede Bitkiler ile Tedavi'. Istanbul University Press, Faculty of Pharmacy No: 3255, 1999.
3. Schempp CM, Haarhaus BS, Termeer CC and Simon JC: Hypericum photo-induced apoptosis involves the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and activation of caspase-8. FEBS Lett 493: 26-30, 2001.
4. Agostinis P, Vantieghem A, Merlevede W and de Witte PAM: Hypericin in cancer treatment: more light on the way. Int J Biochem Cell Biol 34: 221-241, 2002.
5. Hostanska K, Reichling J, Bommer S, Weber M and Saller R: Hyperforin a constituent of St John's wort (Hypericum perforatum L.) extract induces apoptosis by triggering activation of caspases and with hypericin synergistically exerts cytotoxicity towards human malignant cell lines. Eur J Pharm Biopharm 56: 121-132, 2003.
6. Martarelli D, Martarelli B, Pediconi D, Nabissi MI, Perfumi M and Pompei P: Hypericum perforatum methanolic extract inhibits growth of human prostatic carcinoma cell line orthotopically implanted in nude mice. Cancer Lett 210: 27-33, 2004.
7. Wilairat R, Manosroi J, Manosroi A, Kijjoa A, Nascimento MSJ, Pinto M, Silva AMS, Eaton G and Herz W: Cytotoxicities of xhantones and cinnamate esters from Hypericum hookerianum. Planta Med 71: 680-682, 2005.
8. Schempp CM, Kiss J, Kirkin V, Averbeck M, Haarhaus BS, Kremer B, Termeer CC, Sleeman J and Simon JC: Hyperforin acts as an angiogenesis inhibitor in vitro and in vivo. Planta Med 71: 999-1004, 2005.
9. Dell Aica I, Caniato R, Biggin S and Garbisa S: Matrix proteases, green tea and St. John's wort: biomedical research catches up with folk medicine. Clin Chim Acta 381: 69-77, 2007.
10. Ferraz A, Faria, DH, Benneti, MN, da Rocha AB, Schwartsmann G, Henriques A and von Poser GL: Screening for antiproliferative activity of six southern Brazilian species of Hypericum. Phytomedicine 12: 112-115, 2005.
11. Skalkos D, Stavropoulos NE, Tsimaris I, Gioti E, Stalikas CD, Nseyo UO, Ioachim E and Agnantis NJ: The lipophilic extract of Hypericum perforatum exerts significant cytotoxic activity against T24 and NBT-II urinary bladder tumor cells. Planta Med 71: 1030-1035, 2005.
12. Crockett SL, Schaneberg B and Khan IA: Phytochemical profiling of new and old world Hypericum (St. John's Wort) species. Phytochem Anal 16: 479-485, 2005.
13. Krenn L, Presser A, Pradhan R, Bahr B, Paper DH, Mayer KK and Kopp B: Sulfemodin 8-O-beta-D-glucoside, a new sulfated anthraquinone glycoside, and antioxidant phenolic compounds from Rheum emodi. J Nat Prod 66: 1107-1109, 2003.
14. Marchart E, Krenn L and Kopp B: Quantification of the flavonoid glycosides in Passiflora incarnata by capillary electrophoresis. Planta Med 69: 452-456, 2003.
15. Dolezal K, Popa I, Krystof V, Spíchal L, Fojtíková M, Holub J, Lenobel R, Schmülling T and Strnad M: Preparation and biological activity of 6-benzylaminopurine derivatives in plants and human cancer cells. Bioorg Med Chem 14: 875-884, 2006.
16. Grusch M, Polgar D, Gfatter S, Leuhuber K, Huettenbrenner S, Leisser C, Fuhrmann G, Kassie F, Steinkellner H, Smid K, Peters GJ, Jayaram HN, Klepal W, Szekeres T, Knasmuller S and Krupitza G: Maintenance of ATP favours apoptosis over necrosis triggered by benzamide riboside. Cell Death Differ 9: 169-178, 2002.
17. Huettenbrenner S, Maier S, Leisser C, Polgar D, Strasser S, Grusch M and Krupitza G: The evolution of cell death programs as prerequisites of multicellularity. Mutat Res 543: 235-249, 2003.
18. Fernandes-Alnemri T, Litwack G and Alnemri ES: CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme. J Biol Chem 269: 30761-30764, 1994.
19. Piperno G and Fuller M: Monoclonal antibodies specific for an acetylated form of alpha-tubulin recognize the antigen in cilia and flagella from a variety of organisms. J Cell Biol 101: 2085-2094, 1985.
20. Geney R, Sun L, Pera P, Bernacki RJ, Xia S, Horwitz SB, Simmerling CL and Ojima I: Use of the tubulin bound paclitaxel conformation for structure-based rational drug design. Chem Biol 12: 339-348, 2005.
21. Xiao H, Verdier-Pinard P, Fernandez-Fuentes N, Burd B, Angeletti R, Fiser A, Horwitz SB and Orr GA: Insights into the mechanism of microtubule stabilization by Taxol. Proc Natl Acad Sci USA 103: 10166-10173, 2006.
22. Liu Y, Parry JA, Chin A, Duensing S and Duensing A: Soluble histone H2AX is induced by DNA replication stress and sensitizes cells to undergo apoptosis. Mol Cancer 7: 61, 2008.
23. Biroccio A, del Bufalo D, Ricca A, D'Angelo C, D'Orazi G, Sacchi A, Soddu S and Zupi G: Increase of BCNU sensitivity by wt-p53 gene therapy in glioblastoma lines depends on the administration schedule. Gene Ther 6: 1064-1072, 1999.
24. Park KS, Jeon SH, Oh JW and Choi KY: p21Cip/WAF1 activation is an important factor for the ERK pathway dependent anti-proliferation of colorectal cancer cells. Exp Mol Med 36: 557-562, 2004.
25. Facchinetti MM, De Siervi A, Toskos D and Senderowicz AM: UCN-01-induced cell cycle arrest requires the transcriptional induction of p21(waf1/ cip1) by activation of mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway. Cancer Res 64: 3629-3637, 2004.
26. Ebner HL, Blatzer M, Nawaz M and Krumschnabel G: Activation and nuclear translocation of ERK in response to ligand-dependent and -independent stimuli in liver and gill cells from rainbow trout. J Exp Biol 210: 1036-1045, 2007.
27. Pimienta G and Pascual J: Canonical and alternative MAPK signaling. Cell Cycle 6: 2628-2632, 2007.
28. Draetta G and Beach D: Activation of cdc2 protein kinase during mitosis in human cells: cell cycle-dependent phosphorylation and subunit rearrangement. Cell 54: 17-26, 1988.
29. Pines J: Cyclins: wheels within wheels. Cell Growth Differ 2: 305-310, 1991.
30. Lingfei K, Pingzhang Y, Zhengguo L, Jianhua G and Yaowu Z: A study on p16, pRb, cdk4 and cyclinD1 expression in non-small cell lung cancers. Cancer Lett 130: 93-101, 1998.
31. Alao JP: The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention. Mol Cancer 6: 24, 2007.
32. Maier S, Strasser S, Saiko P, Leisser C, Sasgary S, Grusch M, Madlener S, Bader Y, Hartmann J, Schott H, Mader RM, Szekeres T, Fritzer-Szekeres M and Krupitza G: Analysis of mechanisms contributing to AraC-mediated chemoresistance and re-establishment of drug sensitivity by the novel heterodinucleoside phosphate 5-FdUrd-araC. Apoptosis 11: 427-440, 2006.
33. Strasser S, Maier S, Leisser C, Saiko P, Madlener S, Bader Y, Bernhaus A, Gueorguieva M, Richter S, Mader RM, Wesierska-Gadek J, Schott H, Szekeres T, Fritzer-Szekeres M and Krupitza G: 5-FdUrd-araC heterodinucleoside re-establishes sensitivity in 5-FdUrd- and AraC-resistant MCF-7 breast cancer cells overexpressing ErbB2. Differentiation 74: 488-498, 2006.